AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALTERITY THERAPEUTICS LTD

0.505

0.000

Volume:66.79K

Turnover:33.95K

Market Cap:109.84M

PE:-4.54

High:0.515

Open:0.510

Low:0.505

Close:0.505

52wk High:0.785

52wk Low:0.350

Shares:217.51M

Float Shares:149.50M

Volume Ratio:0.24

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.111

EPS(LYR):-0.111

ROE:-54.98%

ROA:-31.75%

PB:2.57

PE(LYR):-4.54

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options

MT Newswires Live

Alterity Therapeutics Limited-$4.2M Options Underwriting Agreement Executed

THOMSON REUTERS

Alterity Therapeutics FY26 Net Loss Widens to $23.4 Million; R&D Expenses Rise 22% to A$17.63 Million

Alterity Therapeutics Limited-Disclosure Under Takeovers Panel Gn 20

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ATH.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATH.AU\",,,,,undefined,":{"symbol":"ATH.AU","market":"AU","secType":"STK","nameCN":"ALTERITY THERAPEUTICS LTD","latestPrice":0.505,"timestamp":1788232110381,"preClose":0.505,"halted":0,"volume":66791,"delay":0,"changeRate":0,"nameEN":"ALTERITY THERAPEUTICS LTD","floatShares":149498066,"shares":217508326,"eps":-0.1112,"marketStatus":"Trading","change":0,"latestTime":"09-01 13:37:23 AEST","open":0.51,"high":0.515,"low":0.505,"amount":33950,"amplitude":0.019802,"askPrice":0.505,"askSize":11996,"bidPrice":0.5,"bidSize":26994,"shortable":3,"etf":0,"ttmEps":-0.1112,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.505,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":0.239758,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ATH.AU","preClose":0.505,"auctionPrice":0.51,"auctionVolume":11984,"auctionTime":1788220747791,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220747791}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATH.AU\",,,,,undefined,":{"symbol":"ATH.AU","floatShares":149498066,"roa":"-31.75%","roe":"-54.98%","lyrEps":-0.1112,"volumeRatio":0.239758,"shares":217508326,"dividePrice":0,"high":0.515,"amplitude":0.019802,"preClose":0.505,"low":0.505,"week52Low":0.35,"pbRate":"2.57","psRate":"20.62","week52High":0.785,"institutionHeld":0,"latestPrice":0.505,"committee":0.384663,"eps":-0.1112,"divideRate":0,"volume":66791,"delay":0,"ttmEps":-0.1112,"open":0.51,"prevYearClose":0.4,"prevWeekClose":0.52,"prevMonthClose":0.505,"prevQuarterClose":0.575,"fiveDayClose":0.51,"twentyDayClose":0.56,"sixtyDayClose":0.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATH.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-06-03","symbol":"ATH.AU","defaultRemindTime":1780444800000,"type":"split","dateTimestamp":1780408800000,"forFactor":50,"toFactor":1,"ratio":50}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATH.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663602953","title":"Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2663602953","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663602953?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:44","pubTimestamp":1788144243,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics  entered into an underwriting agreement with MST Financial Services, under which MST Financial agreed to underwrite the exercise of up to a total of 8.4 million unexercised ATHO listed options ahead of their expiry, according to a Monday Australian bourse filing.There are currently 15.9 million listed ATHO options on issue, exercisable at AU$0.50 and due to expire on Tuesday. MST Financial agreed to underwrite any shortfall arising from options not exercised by optionholders before the expiry date, up to a maximum of 8.4 million options. It will subscribe, or procure subscriptions, for a corresponding number of new fully paid ordinary shares in the firm.MST Financial will receive an underwriting fee of 7% of the gross proceeds raised from the exercise of options underwritten by it.The options are expected to raise around AU$4.2 million before costs, and the proceeds are expected to support continued late-stage clinical development of its ATH434 candidate in multip","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LENZ","BK4139","ATH.AU","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663702858","title":"Alterity Therapeutics Limited-$4.2M Options Underwriting Agreement Executed","url":"https://stock-news.laohu8.com/highlight/detail?id=2663702858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663702858?lang=en_us&edition=fundamental","pubTime":"2026-08-31 07:52","pubTimestamp":1788133923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE7JBTMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","ATH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662956930","title":"Alterity Therapeutics FY26 Net Loss Widens to $23.4 Million; R&D Expenses Rise 22% to A$17.63 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662956930","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662956930?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:16","pubTimestamp":1787922993,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics FY26 net loss widens to $23.4 million; R&D expenses rise 22% to A$17.63 millionAlterity Therapeutics posted a net loss of U.S.$23.4 million, widening from U.S.$12.1 million in the prior year.Operating cash outflow widened to U.S.$22.5 million from U.S.$11.5 million; cash and cash equivalents rose to A$37.32 million.Research and development expenses climbed 22% to A$17.63 million; general and administrative costs jumped 92% to A$10.53 million.Interest income rose to A$1.72 million from A$446,291; other income included A$3.61 million tied to the R&D Tax Incentive.An issued capital consolidation of 50-to-1 took effect on May 29, 2026; unexercised options totaled 66,200,000 at June 30.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL88XH8r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660042321","title":"Alterity Therapeutics Limited-Disclosure Under Takeovers Panel Gn 20","url":"https://stock-news.laohu8.com/highlight/detail?id=2660042321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660042321?lang=en_us&edition=fundamental","pubTime":"2026-08-17 12:52","pubTimestamp":1786942379,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUE25CJDW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATH.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ATH.AU\",params:#limit:6,delay:true,,,undefined,":[]}}